Joseph Allegra
Chairman bij VYSTAR CORPORATION
Vermogen: 320 $ op 31-03-2024
Profiel
Joseph C.
Allegra is currently the Chairman at Vystar Corp.
He previously worked as a Senior Drug Safety Associate at Genentech, Inc. Dr. Allegra completed his undergraduate degree at Boston University and his graduate and doctorate degrees at the University of Georgia.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VYSTAR CORPORATION
0.08% | 31-12-2022 | 10 000 ( 0.08% ) | 320 $ | 31-03-2024 |
Actieve functies van Joseph Allegra
| Bedrijven | Functie | Begin |
|---|---|---|
| VYSTAR CORPORATION | Chairman | 14-02-2018 |
Eerdere bekende functies van Joseph Allegra
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van Joseph Allegra
| Boston University | Undergraduate Degree |
| University of Georgia | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VYSTAR CORPORATION | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
